Laure Gossec to Arthritis, Rheumatoid
This is a "connection" page, showing publications Laure Gossec has written about Arthritis, Rheumatoid.
Connection Strength
3.069
-
Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale. J Rheumatol. 2019 10; 46(10):1259-1267.
Score: 0.291
-
Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis. Clin Rheumatol. 2018 Oct; 37(10):2649-2657.
Score: 0.276
-
Fears and beliefs of people living with rheumatoid arthritis: a systematic literature review. Adv Rheumatol. 2018 May 24; 58(1):1.
Score: 0.275
-
Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients. Clin Rheumatol. 2018 Jun; 37(6):1503-1510.
Score: 0.270
-
The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries. Rheumatology (Oxford). 2018 02 01; 57(2):300-308.
Score: 0.269
-
Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire. Ann Rheum Dis. 2018 02; 77(2):258-263.
Score: 0.265
-
Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial. Clin Exp Rheumatol. 2017 Sep-Oct; 35(5):786-790.
Score: 0.254
-
Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis. Clin Rheumatol. 2017 May; 36(5):1149-1154.
Score: 0.250
-
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146.
Score: 0.085
-
Psychometric properties and cross-language equivalence of the revised Bristol Rheumatoid Arthritis Fatigue and the Rheumatoid Arthritis Impact of Disease scales in rheumatoid arthritis. Qual Life Res. 2019 Sep; 28(9):2543-2552.
Score: 0.073
-
The Portuguese Rheumatoid Arthritis Impact of Disease (RAID) score and its measurement equivalence in three countries: validation study using Rasch Models. Qual Life Res. 2018 Nov; 27(11):2909-2921.
Score: 0.070
-
Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications. Ann Rheum Dis. 2018 12; 77(12):1835-1836.
Score: 0.070
-
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis. Arthritis Res Ther. 2018 06 19; 20(1):129.
Score: 0.069
-
Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis. Ann Rheum Dis. 2018 08; 77(8):1099-1106.
Score: 0.069
-
The controversy of using PGA to define remission in RA. Nat Rev Rheumatol. 2018 03 21; 14(4):245.
Score: 0.068
-
Suppressing Inflammation in Rheumatoid Arthritis: Does Patient Global Assessment Blur the Target? A Practice-Based Call for a Paradigm Change. Arthritis Care Res (Hoboken). 2018 03; 70(3):369-378.
Score: 0.067
-
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis. Ann Rheum Dis. 2018 04; 77(4):476-479.
Score: 0.067
-
The impact of patient global assessment in the definition of remission as a predictor of long-term radiographic damage in patients with rheumatoid arthritis: protocol for an individual patient data meta-analysis. Acta Reumatol Port. 2018 Jan-Mar; 43(1):52-60.
Score: 0.067
-
Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients. Rheumatology (Oxford). 2017 09 01; 56(9):1573-1578.
Score: 0.065
-
Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016. J Rheumatol. 2017 Dec; 44(12):1889-1893.
Score: 0.065
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017 Jun; 76(6):960-977.
Score: 0.063
-
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020 07; 79(7):859-866.
Score: 0.020